BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16406140)

  • 1. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?
    Cheng Y; Seet BL; Ong CS; Wasser S; Tan TM; Peter FJ; Lim SG
    Antiviral Res; 2006 Mar; 69(3):142-51. PubMed ID: 16406140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
    Kazim SN; Chauhan R; Das BC; Sarin SK
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics.
    Misawa N; Matsumoto A; Tanaka E; Rokuhara A; Yoshizawa K; Umemura T; Maki N; Kimura T; Kiyosawa K
    J Med Virol; 2006 Jan; 78(1):68-73. PubMed ID: 16299733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Med Virol; 2004 Oct; 74(2):237-45. PubMed ID: 15332272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
    Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
    J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
    Moriyama K; Okamoto H; Tsuda F; Mayumi M
    Virology; 1996 Dec; 226(2):269-80. PubMed ID: 8955047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis.
    Veazjalali M; Norder H; Magnius L; Jazayeri SM; Alavian SM; Mokhtari-Azad T
    J Viral Hepat; 2009 Apr; 16(4):259-64. PubMed ID: 19222745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands.
    Utsumi T; Yano Y; Truong BX; Tanaka Y; Mizokami M; Seo Y; Kasuga M; Kawabata M; Hayashi Y
    J Med Virol; 2007 Mar; 79(3):229-35. PubMed ID: 17245721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
    Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
    J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors.
    Sallam TA; Tong CY
    J Med Virol; 2002 Nov; 68(3):328-34. PubMed ID: 12226818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
    Wu W; Chen Y; Ruan B; Li LJ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
    Fujiwara K; Tanaka Y; Paulon E; Orito E; Sugiyama M; Ito K; Ueda R; Mizokami M; Naoumov NV
    J Virol; 2005 Nov; 79(22):14404-10. PubMed ID: 16254374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.